← Back to Screener
Hercules Capital, Inc. (HTGC)
Price$15.64
Favorite Metrics
Price vs S&P 500 (26W)-15.45%
Price vs S&P 500 (4W)2.61%
Market Capitalization$2.88B
P/E Ratio (Annual)8.48x
Indicated Dividend Yield (Annual)10.20%
All Metrics
Book Value / Share (Quarterly)$12.13
P/TBV (Annual)1.69x
Indicated Dividend (Annual)$1.89
Revenue Growth (3Y)18.29%
Cash Flow / Share (Quarterly)$-2.33
Payout Ratio (TTM)95.95%
Price vs S&P 500 (YTD)-19.33%
Gross Margin (TTM)80.62%
Net Profit Margin (TTM)63.80%
EPS (TTM)$1.78
10-Day Avg Trading Volume1.96M
EPS Excl Extra (TTM)$1.78
Revenue Growth (5Y)13.13%
EPS (Annual)$1.80
Dividend / Share (Annual)$1.85
ROI (Annual)7.55%
Gross Margin (Annual)80.62%
Net Profit Margin (5Y Avg)56.81%
Cash / Share (Quarterly)$0.31
P/E Basic Excl Extra (TTM)8.48x
Revenue Growth QoQ (YoY)12.85%
EPS Growth (5Y)-2.33%
P/E Normalized (Annual)8.48x
ROA (Last FY)7.41%
Revenue Growth TTM (YoY)7.88%
EBITD / Share (TTM)$1.81
ROE (5Y Avg)13.57%
Operating Margin (TTM)64.14%
Cash Flow / Share (Annual)$-2.33
P/B Ratio1.30x
P/B Ratio (Quarterly)1.54x
Net Income / Employee (Annual)$3
EV / Revenue (TTM)9.60x
Net Interest Coverage (TTM)189.85x
ROA (TTM)7.85%
EPS Growth QoQ (YoY)24.51%
EV / EBITDA (TTM)14.95x
EPS Incl Extra (Annual)$1.80
Current Ratio (Annual)1.16x
Quick Ratio (Quarterly)1.16x
3-Month Avg Trading Volume2.27M
52-Week Price Return-8.25%
P/E Incl Extra (TTM)8.48x
Revenue / Employee (TTM)$5
Tangible BV / Share (Quarterly)$10.93
P/S Ratio (Annual)5.41x
Asset Turnover (Annual)0.12x
52-Week High$19.67
Operating Margin (5Y Avg)61.04%
EPS Excl Extra (Annual)$1.80
CapEx CAGR (5Y)-2.30%
Tangible BV CAGR (5Y)10.75%
26-Week Price Return-11.46%
Quick Ratio (Annual)1.16x
13-Week Price Return-16.02%
Total Debt / Equity (Annual)1.03x
Current Ratio (Quarterly)1.16x
Enterprise Value$5,109.802
Revenue / Share Growth (5Y)1.96%
Asset Turnover (TTM)0.12x
Book Value / Share Growth (5Y)1.50%
Revenue / Employee (Annual)$5
Pretax Margin (Annual)63.80%
Cash / Share (Annual)$0.31
3-Month Return Std Dev33.57%
Gross Margin (5Y Avg)80.91%
Net Income / Employee (TTM)$3
EBITDA CAGR (5Y)16.75%
EBITDA Interim CAGR (5Y)15.51%
ROE (Last FY)15.33%
Net Interest Coverage (Annual)4.66x
EPS Basic Excl Extra (Annual)$1.80
P/FCF (TTM)10.21x
Receivables Turnover (TTM)15.23x
EV / Free Cash Flow (TTM)339.36x
Total Debt / Equity (Quarterly)1.03x
EPS Incl Extra (TTM)$1.78
Receivables Turnover (Annual)13.12x
ROI (TTM)7.98%
Dividend Growth Rate (5Y)6.10%
P/S Ratio (TTM)5.41x
Pretax Margin (5Y Avg)56.81%
Revenue / Share (Annual)$2.82
Tangible BV / Share (Annual)$10.53
Forward P/E8.02x
Price vs S&P 500 (52W)-38.08%
P/E Ratio (TTM)8.48x
EPS Growth TTM (YoY)-18.76%
Year-to-Date Return-16.68%
5-Day Price Return6.38%
EPS Normalized (Annual)$1.80
ROA (5Y Avg)6.84%
Net Profit Margin (Annual)63.80%
Month-to-Date Return6.16%
Cash Flow / Share (TTM)$2.00
EBITD / Share (Annual)$1.81
EPS Growth (3Y)30.70%
Operating Margin (Annual)64.14%
LT Debt / Equity (Annual)1.03x
ROI (5Y Avg)6.98%
P/E Excl Extra (TTM)8.48x
LT Debt / Equity (Quarterly)1.03x
EPS Basic Excl Extra (TTM)$1.78
P/TBV (Quarterly)1.43x
Payout Ratio (Annual)95.95%
P/B Ratio (Annual)1.54x
Dividend / Share (TTM)$1.85
Pretax Margin (TTM)63.80%
Book Value / Share (Annual)$12.13
Price vs S&P 500 (13W)-16.70%
Net Margin Growth (5Y)-4.21%
Dividend Yield (TTM)11.32%
Beta0.77x
P/FCF (Annual)42.74x
Revenue / Share (TTM)$2.71
ROE (TTM)15.88%
52-Week Low$13.70
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.20
4.20
4.13
4.13
About
Hercules Capital is a specialty finance company providing senior secured loans to high-growth, venture-backed companies in technology and life sciences. The company invests primarily in structured debt instruments across sectors including software, semiconductors, medical devices, and biopharmaceuticals, targeting attractive yields and portfolio growth.